Japan’s Taisho Pharmaceutical looks like it could be heading into private ownership, thanks to a management buyout offer (MBO) that could value the company at almost $5 billion. The consumer ...

After protracted speculation, Bristol-Myers Squibb has confirmed it plans to divest its French over-the-counter (OTC) medicines business UPSA to Japan’s Taisho Pharma in a $1.6 billion deal.

ISE, Mie Prefecture--Recently discovered film footage from the Taisho Era (1912-1926 ... is now being shown at the Museum of Shinto and Japanese Culture on the university’s campus.